Skip to main content

Telix Pharmaceuticals Limited (NASDAQ: TLX) Investor Securities Class Action Lawsuit 11/10/2025

  • If you purchased a significant amount of shares of Telix Pharmaceuticals Limited (NASDAQ: TLX) between February 21, 2025 and August 28, 2025, and / or if you purchased any NASDAQ: TLX shares prior to February 2025 and continue to hold any of those shares, you have certain options and for certain investors are short and strict deadlines running. Deadline: January 9, 2026. NASDAQ: TLX investors should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

November 10, 2025 - An investor in shares of Telix Pharmaceuticals Limited (NASDAQ: TLX) filed a lawsuit in the U.S. District Court for the Southern District of Indiana over alleged violations of Federal Securities Laws by Telix Pharmaceuticals Limited in connection with certain allegedly false and misleading statements made between February 21, 2025 and August 28, 2025.   Australia b...



You must register (for free) or login to view the entire case.